Vera TherapeuticsVERA
13F holders, Q4 2024 (December 31)178holders +5
23new positions
23sold out
7famous investors
$42.29avg. 13F price*
At the end of Q4 2024, 178 institutions reported holding Vera Therapeutics Inc. (VERA) in their 13F filings, up 5 from Q3 2024. 23 opened new positions and 23 sold out. The largest holders were Avoro Capital Advisors LLC ($237.2M), T. Rowe Price Associates Inc. ($185.1M) and BlackRock, Inc. ($166.7M). 7 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Vera Therapeutics Inc.
- CUSIP
- 92337R101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 23 | $83.6M |
| Exits | 23 | $29.2M |
All 13F filers, Q3 2024 → Q4 2024: 13,121,802 shares bought and 3,849,270 shares sold, net +9,272,532 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 178 holders
| Avoro Capital Advisors LLC | 3.36% | Add +30.2% | 5,610,000 | $237.2M |
| T. Rowe Price Associates Inc. | 0.02% | Add +11.1% | 4,377,049 | $185.1M |
| BlackRock, Inc. | 0.00% | Add +14.2% | 3,941,486 | $166.7M |
| FMR LLC | 0.01% | Add +9.6% | 3,053,126 | $129.1M |
| Vanguard Group Inc. | 0.00% | Add +14.3% | 2,949,564 | $124.7M |
| Sofinnova Investments, Inc. | 8.66% | No change | 2,793,987 | $118.2M |
| State Street Corp. | 0.00% | Add +11.1% | 2,026,352 | $85.7M |
| Commodore Capital LP | 6.07% | Reduce -20.9% | 1,958,600 | $82.8M |
| Holocene Advisors, LP | 0.26% | Reduce -4.0% | 1,875,963 | $79.3M |
| Samlyn Capital, LLC | 1.12% | Add +22.3% | 1,662,220 | $70.3M |
| Eversept Partners, LP | 6.98% | Reduce -22.0% | 1,600,015 | $67.7M |
| Kynam Capital Management, LP | 4.07% | Reduce -7.5% | 1,457,910 | $61.7M |
| Paradigm Biocapital Advisors LP | 2.11% | Add +31.0% | 1,437,339 | $60.8M |
| T. Rowe Price Investment Management, Inc. | 0.04% | Add +43.8% | 1,415,179 | $59.8M |
| First Light Asset Management, LLC | 5.10% | Add +78.8% | 1,261,246 | $53.3M |
| Woodline Partners LP | 0.34% | Add +20.1% | 1,202,466 | $50.9M |
| Lord, Abbett & Co. LLC | 0.16% | Add +170.8% | 1,153,670 | $48.8M |
| Geode Capital Management, LLC | 0.00% | Add +14.8% | 1,153,325 | $48.8M |
| Integral Health Asset Management, LLC | 4.30% | Add +130.0% | 1,150,000 | $48.6M |
| Federated Hermes, Inc. | 0.10% | Add +162.3% | 1,085,986 | $45.9M |
| Vestal Point Capital, LP | 2.70% | New | 1,075,000 | $45.5M |
| Logos Global Management LP | 4.33% | Add +75.0% | 875,000 | $37.0M |
| Pictet Asset Management Holding SA | 0.04% | Add +47.1% | 841,313 | $35.6M |
| Marshall Wace, LLP | 0.04% | Add +43.4% | 837,146 | $35.4M |
| Jennison Associates LLC | 0.02% | Add +82.0% | 813,861 | $34.4M |
| Deutsche Bank AG | 0.01% | Add +5.7% | 810,376 | $34.3M |
| Siren, L.L.C. | 1.42% | Reduce -9.5% | 758,465 | $32.1M |
| Orbimed Advisors LLC | 0.65% | Add +9.9% | 742,572 | $31.4M |
| Voya Investment Management LLC | 0.04% | Add +572.2% | 695,091 | $29.4M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -7.5% | 554,729 | $23.5M |
| Rock Springs Capital Management LP | 0.79% | Add +27.2% | 487,863 | $20.6M |
| Schroder Investment Management Group | 0.02% | Add +1.8% | 485,145 | $20.4M |
| Adage Capital Partners Gp, L.L.C. | 0.04% | Reduce -65.1% | 480,000 | $20.3M |
| First Turn Management, LLC | 3.52% | Add +42.4% | 464,807 | $19.7M |
| Northern Trust Corp. | 0.00% | Add +24.6% | 455,007 | $19.2M |
| Altium Capital Management LLC | 5.69% | Reduce -36.8% | 432,000 | $18.3M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +19.0% | 430,665 | $18.2M |
| American Century Companies Inc. | 0.01% | Add +11.0% | 428,940 | $18.1M |
| Affinity Asset Advisors, LLC | 3.06% | Reduce -2.3% | 425,000 | $18.0M |
| Balyasny Asset Management L.P. | 0.04% | Add +119.5% | 385,425 | $16.3M |
| Candriam S.C.A. | 0.09% | Reduce -18.9% | 365,999 | $15.5M |
| Morgan Stanley | 0.00% | Reduce -3.7% | 328,515 | $13.9M |
| MPM Bioimpact LLC | 1.55% | New | 257,788 | $10.9M |
| AXA S.A. | 0.03% | Reduce -0.2% | 245,879 | $10.4M |
| Alphabet Inc. | 0.59% | No change | 241,264 | $10.2M |
| Victory Capital Management Inc. | 0.01% | Add +515.0% | 235,267 | $9.9M |
| TD Asset Management Inc | 0.01% | Add +19.5% | 230,558 | $9.8M |
| JPMorgan Chase & Co. | 0.00% | Add +71.6% | 221,485 | $9.4M |
| Cutter Capital Management, LP | 3.69% | Add +23.0% | 212,696 | $9.0M |
| Point72 Asset Management | 0.02% | Add +13.1% | 194,027 | $8.2M |
| Readystate Asset Management LP | 0.61% | Add +296.6% | 189,088 | $8.0M |
| GW&K Investment Management, LLC | 0.07% | New | 186,605 | $7.9M |
| Armistice Capital, LLC | 0.18% | New | 178,283 | $7.5M |
| Qube Research & Technologies Ltd | 0.01% | Add +1174.6% | 170,486 | $7.2M |
| Crestline Management, L.P. | 0.24% | Add +97.2% | 160,347 | $6.8M |
| Nuveen Asset Management, LLC | 0.00% | Reduce -2.0% | 155,825 | $6.6M |
| Bank of New York Mellon Corp | 0.00% | Add +5.9% | 141,948 | $6.0M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +26.0% | 128,380 | $5.4M |
| Platinum Investment Management Ltd. | 0.30% | Reduce -12.9% | 119,664 | $5.1M |
| Citigroup Inc. | 0.00% | Add +299.6% | 117,484 | $5.0M |
| Schonfeld Strategic Advisors LLC | 0.03% | Reduce -40.5% | 116,915 | $4.9M |
| Cinctive Capital Management LP | 0.26% | Add +134.1% | 113,546 | $4.8M |
| Springhill Fund Asset Management (HK) Co Ltd | 7.51% | — | 109,400 | $4.6M |
| Nicholas Investment Partners, LP | 0.44% | Add +49.3% | 106,805 | $4.5M |
| Pier Capital, LLC | 0.62% | Reduce -1.3% | 102,128 | $4.3M |
| Avidity Partners Management LP | 0.42% | New | 100,000 | $4.2M |
| Barclays PLC | 0.00% | Add +16.1% | 99,148 | $4.2M |
| UBS Group AG | 0.00% | Add +18.1% | 97,303 | $4.1M |
| Rafferty Asset Management, LLC | 0.01% | Add +11.1% | 87,686 | $3.7M |
| Swiss National Bank | 0.00% | Add +22.5% | 85,400 | $3.6M |
| Prudential Financial Inc. | 0.00% | Add +33.6% | 83,077 | $3.5M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +30.1% | 80,106 | $3.4M |
| Millennium Management | 0.00% | Reduce -73.8% | 77,648 | $3.3M |
| D. E. Shaw & Co. | 0.00% | Reduce -42.9% | 74,476 | $3.1M |
| EFG Asset Management (North America) Corp. | 0.42% | Add +59.1% | 73,160 | $3.1M |
| Raymond James Financial Inc. | 0.00% | — | 69,724 | $2.9M |
| Thornburg Investment Management Inc. | 0.03% | Add +91.1% | 59,004 | $2.5M |
| Rhumbline Advisers | 0.00% | Add +12.5% | 58,589 | $2.5M |
| Cubist Systematic Strategies, LLC | 0.04% | Reduce -44.2% | 56,921 | $2.4M |
| Eastern Bank | 0.04% | No change | 56,050 | $2.4M |
| Citadel Advisors | 0.00% | Add +1685.2% | 54,806 | $2.3M |
| State of Wisconsin Investment Board | 0.01% | Add +52.2% | 54,599 | $2.3M |
| HighVista Strategies LLC | 0.82% | Add +137.2% | 52,197 | $2.2M |
| Alps Advisors Inc. | 0.01% | Add +15.7% | 51,207 | $2.2M |
| Decheng Capital LLC | 0.45% | Reduce -28.7% | 49,767 | $2.1M |
| Norges Bank | 0.00% | New | 48,593 | $2.1M |
| Legal & General Group Plc | 0.00% | Add +21.1% | 47,809 | $2.0M |
| Wexford Capital LP | 0.47% | Reduce -7.1% | 43,521 | $1.8M |
| Two Sigma Investments, LP | 0.00% | Reduce -14.6% | 41,451 | $1.8M |
| California State Teachers Retirement System | 0.00% | Add +19.9% | 40,640 | $1.7M |
| Alliancebernstein L.P. | 0.00% | Add +2.0% | 40,350 | $1.7M |
| Wells Fargo & Company | 0.00% | Add +229.7% | 39,576 | $1.7M |
| Algert Global LLC | 0.04% | Add +66.4% | 38,550 | $1.6M |
| Renaissance Technologies | 0.00% | New | 35,700 | $1.5M |
| Tudor Investment Corporation | 0.01% | Add +30.1% | 31,843 | $1.3M |
| Bank of America Corp. | 0.00% | Reduce -77.9% | 30,244 | $1.3M |
| Jain Global LLC | 0.04% | — | 30,204 | $1.3M |
| Ameriprise Financial Inc. | 0.00% | Add +31.7% | 30,021 | $1.3M |
| New York State Common Retirement Fund | 0.00% | Add +19.5% | 28,822 | $1.2M |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +34.6% | 28,695 | $1.2M |
"% of holder's portfolio" is VERA's weight in each manager's 13F, not the share of Vera Therapeutics Inc. the manager owns.